You just read:

Helsinn Group and MEI Pharma Announce Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia

News provided by

MEI Pharma, Inc.

May 18, 2017, 09:00 ET